List of Tables
Table 1. Global Integrin Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Integrin Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Integrin Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global Integrin Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Integrin Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Integrin Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Integrin Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Integrin Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Integrin Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Integrin Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Integrin Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of Integrin Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Integrin Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on Integrin Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Integrin Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Integrin Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global Integrin Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global Integrin Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global Integrin Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global Integrin Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global Integrin Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global Integrin Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global Integrin Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America Integrin Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Integrin Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America Integrin Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America Integrin Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America Integrin Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Integrin Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Integrin Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe Integrin Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe Integrin Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Integrin Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Integrin Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Integrin Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Integrin Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Integrin Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Integrin Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Integrin Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Integrin Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America Integrin Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America Integrin Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Integrin Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Integrin Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Integrin Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Integrin Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Integrin Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Integrin Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global Integrin Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global Integrin Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global Integrin Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global Integrin Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global Integrin Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Integrin Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Integrin Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global Integrin Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global Integrin Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global Integrin Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global Integrin Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global Integrin Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global Integrin Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global Integrin Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global Integrin Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Integrin Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Integrin Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global Integrin Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global Integrin Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global Integrin Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Merck Integrin Inhibitors Product
Table 74. Merck Recent Developments/Updates
Table 75. Gland Pharma
Taj Pharmaceuticals Company Information
Table 76. Gland Pharma
Taj Pharmaceuticals Description and Business Overview
Table 77. Gland Pharma
Taj Pharmaceuticals Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Gland Pharma
Taj Pharmaceuticals Integrin Inhibitors Product
Table 79. Gland Pharma
Taj Pharmaceuticals Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. GlaxoSmithKline Integrin Inhibitors Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Takeda Company Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Takeda Integrin Inhibitors Product
Table 89. Takeda Recent Developments/Updates
Table 90. Correvio Company Information
Table 91. Correvio Description and Business Overview
Table 92. Correvio Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Correvio Integrin Inhibitors Product
Table 94. Correvio Recent Developments/Updates
Table 95. Medicure Company Information
Table 96. Medicure Description and Business Overview
Table 97. Medicure Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Medicure Integrin Inhibitors Product
Table 99. Medicure Recent Developments/Updates
Table 100. Johnson & Johnson Company Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Johnson & Johnson Integrin Inhibitors Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Eli Lilly Company Information
Table 106. Eli Lilly Description and Business Overview
Table 107. Eli Lilly Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Eli Lilly Integrin Inhibitors Product
Table 109. Eli Lilly Recent Developments/Updates
Table 110. Bio-Thera Solutions Company Information
Table 111. Bio-Thera Solutions Description and Business Overview
Table 112. Bio-Thera Solutions Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Bio-Thera Solutions Integrin Inhibitors Product
Table 114. Bio-Thera Solutions Recent Developments/Updates
Table 115. Biogen Company Information
Table 116. Biogen Description and Business Overview
Table 117. Biogen Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Biogen Integrin Inhibitors Product
Table 119. Biogen Recent Developments/Updates
Table 120. Novartis Company Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Novartis Integrin Inhibitors Product
Table 124. Novartis Recent Developments/Updates
Table 125. Sandoz Company Information
Table 126. Sandoz Description and Business Overview
Table 127. Sandoz Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sandoz Integrin Inhibitors Product
Table 129. Sandoz Recent Developments/Updates
Table 130. Polpharma Biologics Company Information
Table 131. Polpharma Biologics Description and Business Overview
Table 132. Polpharma Biologics Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Polpharma Biologics Integrin Inhibitors Product
Table 134. Polpharma Biologics Recent Developments/Updates
Table 135. Alvotech Company Information
Table 136. Alvotech Description and Business Overview
Table 137. Alvotech Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Alvotech Integrin Inhibitors Product
Table 139. Alvotech Recent Developments/Updates
Table 140. Yangtze River Pharmaceutical Company Information
Table 141. Yangtze River Pharmaceutical Description and Business Overview
Table 142. Yangtze River Pharmaceutical Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Yangtze River Pharmaceutical Integrin Inhibitors Product
Table 144. Yangtze River Pharmaceutical Recent Developments/Updates
Table 145. Lunan Pharma Company Information
Table 146. Lunan Pharma Description and Business Overview
Table 147. Lunan Pharma Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Lunan Pharma Integrin Inhibitors Product
Table 149. Lunan Pharma Recent Developments/Updates
Table 150. Kelun Pharma Company Information
Table 151. Kelun Pharma Description and Business Overview
Table 152. Kelun Pharma Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Kelun Pharma Integrin Inhibitors Product
Table 154. Kelun Pharma Recent Developments/Updates
Table 155. Grand Pharmaceutical Company Information
Table 156. Grand Pharmaceutical Description and Business Overview
Table 157. Grand Pharmaceutical Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Grand Pharmaceutical Integrin Inhibitors Product
Table 159. Grand Pharmaceutical Recent Developments/Updates
Table 160. Tianjin Chase Sun Pharma Company Information
Table 161. Tianjin Chase Sun Pharma Description and Business Overview
Table 162. Tianjin Chase Sun Pharma Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Tianjin Chase Sun Pharma Integrin Inhibitors Product
Table 164. Tianjin Chase Sun Pharma Recent Developments/Updates
Table 165. SJZ No.4 Pharmaceutical Company Information
Table 166. SJZ No.4 Pharmaceutical Description and Business Overview
Table 167. SJZ No.4 Pharmaceutical Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. SJZ No.4 Pharmaceutical Integrin Inhibitors Product
Table 169. SJZ No.4 Pharmaceutical Recent Developments/Updates
Table 170. Huadong Medicin Company Information
Table 171. Huadong Medicin Description and Business Overview
Table 172. Huadong Medicin Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Huadong Medicin Integrin Inhibitors Product
Table 174. Huadong Medicin Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Integrin Inhibitors Distributors List
Table 178. Integrin Inhibitors Customers List
Table 179. Integrin Inhibitors Market Trends
Table 180. Integrin Inhibitors Market Drivers
Table 181. Integrin Inhibitors Market Challenges
Table 182. Integrin Inhibitors Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Integrin Inhibitors
Figure 2. Global Integrin Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Integrin Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Antibodies Product Picture
Figure 5. Small Molecules Product Picture
Figure 6. Others Product Picture
Figure 7. Global Integrin Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Integrin Inhibitors Market Share by Application: 2025 & 2032
Figure 9. Cardiovascular Disease
Figure 10. Autoimmune Disease
Figure 11. Tumor
Figure 12. Other
Figure 13. Global Integrin Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Integrin Inhibitors Market Size (US$ Million), 2021–2032
Figure 15. Global Integrin Inhibitors Sales (K Units), 2021–2032
Figure 16. Global Integrin Inhibitors Average Price (US$/Unit), 2021–2032
Figure 17. Integrin Inhibitors Report Years Considered
Figure 18. Integrin Inhibitors Sales Share by Manufacturers in 2025
Figure 19. Global Integrin Inhibitors Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Integrin Inhibitors Players: Market Share by Revenue in Integrin Inhibitors in 2025
Figure 21. Integrin Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Integrin Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Integrin Inhibitors Sales Market Share by Country (2021–2032)
Figure 24. North America Integrin Inhibitors Revenue Market Share by Country (2021–2032)
Figure 25. United States Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Integrin Inhibitors Sales Market Share by Country (2021–2032)
Figure 28. Europe Integrin Inhibitors Revenue Market Share by Country (2021–2032)
Figure 29. Germany Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Integrin Inhibitors Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Integrin Inhibitors Revenue Market Share by Region (2021–2032)
Figure 36. China Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Integrin Inhibitors Sales Market Share by Country (2021–2032)
Figure 44. Latin America Integrin Inhibitors Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Integrin Inhibitors Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Integrin Inhibitors Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Integrin Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Integrin Inhibitors by Type (2021–2032)
Figure 55. Global Revenue Market Share of Integrin Inhibitors by Type (2021–2032)
Figure 56. Global Integrin Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Integrin Inhibitors by Application (2021–2032)
Figure 58. Global Revenue Market Share of Integrin Inhibitors by Application (2021–2032)
Figure 59. Global Integrin Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 60. Integrin Inhibitors Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
